HuGE Literature Finder
Records
1
-
10
| Correlation between Programmed Death Ligand-1(PD-L1) Expression and Driver Gene Mutations in Non-Small Cell Lung Carcinoma- Adenocarcinoma Phenotype. Asian Pacific journal of cancer prevention : APJCP 2022 Jan 23 (1): 131-142. Pandey Rahul Kumar, Shukla Saumya, Husain Nuzhat, Islam Mohammad Hayatul, Hadi Rahat, Kant Tripathi Surya, Singhal Ashi |
| Integration of clinicopathological and mutational data offers insight into lung cancer with tumor spread through air spaces. Annals of translational medicine 2021 Jun 9 (12): 985. Tian Yu, Feng Jing, Jiang Long, Ning Junwei, Gu Zenan, Huang Jia, Luo Qingqu |
| Genotyping and cytomorphological subtyping of lung adenocarcinoma based on liquid-based cytology. Diagnostic cytopathology 2019 Feb . Tanaka Ryota, Sakamoto Norihiko, Suzuki Hitomi, Tachibana Keisei, Ohtsuka Kouki, Kishimoto Koji, Fujiwara Masachika, Kamma Hiroshi, Shibahara Junji, Kondo Haruhi |
| Aberrant status and clinicopathologic characteristic associations of 11 target genes in 1,321 Chinese patients with lung adenocarcinoma. Journal of thoracic disease 2018 Jan 10 (1): 398-407. Zhao Mengnan, Zhan Cheng, Li Ming, Yang Xiaodong, Yang Xinyu, Zhang Yong, Lin Miao, Xia Yifeng, Feng Mingxiang, Wang Q |
| MET Expression in Advanced Non-Small-Cell Lung Cancer: Effect on Clinical Outcomes of Chemotherapy, Targeted Therapy, and Immunotherapy. Clinical lung cancer 2018 07 19 (4): e441-e463. Reis Henning, Metzenmacher Martin, Goetz Moritz, Savvidou Nikoleta, Darwiche Kaid, Aigner Clemens, Herold Thomas, Eberhardt Wilfried E, Skiba Charlotte, Hense Jörg, Virchow Isabel, Westerwick Daniela, Bogner Simon, Ting Saskia, Kasper Stefan, Stuschke Martin, Nensa Felix, Herrmann Ken, Hager Thomas, Schmid Kurt W, Schuler Martin, Wiesweg Marc |
| Survival difference according to mutation status in a prospective cohort study of Australian patients with metastatic non-small-cell lung carcinoma. Internal medicine journal 2018 01 48 (1): 37-44. Tan Lavinia, Alexander Marliese, Officer Ann, MacManus Michael, Mileshkin Linda, Jennens Ross, Herath Dishan, de Boer Richard, Fox Stephen B, Ball David, Solomon Benjam |
| Unique prevalence of oncogenic genetic alterations in young patients with lung adenocarcinoma. Cancer 2017 Feb . Tanaka Kosuke, Hida Toyoaki, Oya Yuko, Yoshida Tatsuya, Shimizu Junichi, Mizuno Tetsuya, Kuroda Hiroaki, Sakakura Noriaki, Yoshimura Kenichi, Horio Yoshitsugu, Sakao Yukinori, Yatabe Yasus |
| [Gene Expression and Clinical Characteristics of Molecular Targeted Therapy ?in Non-small Cell Lung Cancer Patients in Shandong]. Zhongguo fei ai za zhi = Chinese journal of lung cancer 2017 Jan 20 (1): 14-20. Qiao Xiuli, Ai Dan, Liang Honglu, Mu Dianbin, Guo Qis |
| Efficacy of Pemetrexed-Based Chemotherapy in Patients with ROS1 Fusion-Positive Lung Adenocarcinoma Compared with in Patients Harboring Other Driver Mutations in East Asian Populations. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2016 Apr . Chen Yen-Fu, Hsieh Min-Shu, Wu Shang-Gin, Chang Yih-Leong, Yu Chong-Jen, Yang James Chih-Hsin, Yang Pan-Chyr, Shih Jin-Yu |
| Clinical and prognostic implications of ALK and ROS1 rearrangements in never-smokers with surgically resected lung adenocarcinoma. Lung cancer (Amsterdam, Netherlands) 2014 Mar 83 (3): 389-95. Kim Min Hwan, Shim Hyo Sup, Kang Dae Ryong, Jung Ji Ye, Lee Chang Young, Kim Dae Joon, Lee Jin Gu, Bae Mi Kyung, Kim Hye Ryun, Lim Sun Min, Kim Eun Young, Park Ji Soo, Chung Kyung Young, Kim Hyun-Jung, Kim Joo Hang, Cho Byoung Ch |
- Page last reviewed:Oct 1, 2021
- Page last updated:Jul 06, 2022
- Content source: